Merck's biosimilar to AbbVie's Humira wins FDA approval

Merck's biosimilar to AbbVie's Humira wins FDA approval

Submitted by admin on July 23, 2019 - 7:35pm
Source: 
Reuters
News Tags: 
Merck
Hadlima
biosimilars
FDA
AbbVie
Humira
Headline: 
Merck's biosimilar to AbbVie's Humira wins FDA approval
snippet: 

The U.S. Food and Drug Administration approved Merck & Co Inc’s biosimilar to AbbVie Inc’s blockbuster rheumatoid arthritis treatment Humira, the health agency said on Tuesday.

Do Not Allow Advertisers to Use My Personal information